Precision Neuroscience develops brain-computer interfaces for people with paralysis.
Precision Neuroscience has raised $250.0M in total funding. The most recent round was Series D. The last funding was announced in September 2026.
Precision Neuroscience's investors include Ackman Oxman Institute, Alumni Ventures, ARK Investment Management, Mubadala Capital, Draper Associates.
Precision Neuroscience is headquartered in Manhattan, United States.
Precision Neuroscience develops brain-computer interfaces for people with paralysis.
Precision Neuroscience is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Precision Neuroscience — Funding & Investors." VCBacked, September 24, 2026, https://www.vcbacked.co/company/precision-neuroscience. Accessed October 30, 2026.
VCBacked. (2026). Precision Neuroscience — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/precision-neuroscience
{{cite web |title=Precision Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/precision-neuroscience |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated